Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Body Weight 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prebiotics × 1 year × Clear all
NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Instituto Jalisciense de Cancerologia

Phase NA Enrolling by invitation
80 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT05826184 2025-10-03

Time Restricted Eating With or Without a Fiber Supplement for Weight Management in Pediatric Cancer Survivors

University of Illinois at Chicago

Phase NA Completed
13 enrolled

Body Weight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡